TABLE 2

AEs Noted from Radiopharmaceuticals

Event	Radiopharmaceutical
Cutaneous (rash, flush)	^99mTc-DMSA^†, ¹⁸F-FDG, ¹¹¹In-WBC^*, ¹¹¹In-WBC/^99mTc-SC/^99mTc-MDP, ^99mTc-MAG3/furosemide, ^99mTc-MDP, ^99mTc-MDP/^99mTc-SC, ¹²³I-MIBG (2 patients)^†, cold pyp^†, ^99mTc-sestamibi, ¹³¹I-tositumomab
Nausea	¹²³I-MIBG (2 patients)^†, ^99mTc-DMSA^†
Cardiovascular (anaphylactoid, hypotension, cardiac arrest)	^99mTc-MDP (2 patients)^, ^99mTc-SC, ¹⁸F-FDG^, ^99mTc-MAG3/furosemide
Neurologic (pain, hypesthesia, paresthesia)	Cold pyp^†, ^99mTc-sestamibi^, ^99mTc-tetrofosmin (2 patients)^

↵* Judged as unlikely by study criteria, totaling 5 AEs; if 2 patients are noted as having had AEs, only one was deemed unlikely in this study.
↵† Three patients (1 each from ^99mTc-DMSA, ¹²³I-MIBG, cold pyp) had 2 symptoms or signs from radiopharmaceuticals, but these were counted as 1 AE from 1 radiopharmaceutical that caused 2 symptoms.
DMSA = dimercaptosuccinic acid; WBC = white blood cells; SC = sulfur colloid; MDP = methylene diphosphonate; MAG3 = mercaptoacetyltriglycine; MIBG = metaiodobenzylguanidine; pyp = pyrophosphate.